PERSPECTA

News from every angle

← Back to headlines

Twist Bioscience Signals Strong Q4 Revenue and Raises Fiscal 2026 Outlook

Twist Bioscience has indicated Q4 revenue between $123M-$124M and increased its fiscal 2026 outlook to $456M-$457M, signaling robust financial performance.

3 Aug, 18:40 — 3 Aug, 18:40
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1h ago

Twist Bioscience signals $123M-$124M Q4 revenue as fiscal 2026 outlook rises to $456M-$457M

Read full article →

Related Stories

US Trial Begins for UN Worker Killed in Boeing 737 MAX Crash

17m ago

La Rosa Holdings Reports GAAP EPS of -$72.03 and Revenue of $13.57M

19m ago

Fresenius Medical Care Reports GAAP EPS of EUR0.81 and Revenue of EUR4.86B

21m ago

Alexander's Reports GAAP EPS of $30.24 and Revenue of $54.7M

22m ago